Sandoz (pre-1996)
AskBiography Logo   Latest News  Follow Us on Twitter  Follow Us on Google Buzz  Became Fan - Facebook  Subscribe to RSSRSS   Bookmark and Share

Novartis

Company nameNovartis International AG
Company typePublic (SWX - NOVN, NYSE - NVS)
IndustryPharmaceutical industry
Founded1996 (from merger)
HeadquartersBasel, Switzerland
Key peopleDaniel Vasella (Chairman of the board) Joseph Jimenez (CEO)
ProductsPharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
RevenueUS $44.27 billion (2009)
Operating income(+) US $9.98 billion (2009)
Net income(+) US $8.40 billion (2009)
Employees99,830 (FTE, 2009)
SubsidiaryCiba Vision, Sandoz

     Home | Company | Sandoz (pre-1996)



Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number three in sales among the world-wide industry, which accounted 36.173 billon in 2008.

It currently is the sixth largest pharmaceutical company in terms of revenue ($41.5 billion in 2009) with a profit margin of about 20%, which is the same as its industry competitors. Their profits were down by 31% from 2007 levels.

Novartis manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), ciclosporin (Neoral / Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. Renamed to Novartis following an acquisition by Ciba-Geigy, it owns Sandoz, a large manufacturer of generic drugs. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on 1 September 2007.

Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)

Latest News : Sandoz (pre-1996) : Tweet this RSS

Want to Sandoz (pre-1996) latest news on your twitter account???   sign in with twitter
Sandoz (pre-1996)     sign in with twitter   ||  Company     sign in with twitter   ||  Economy     sign in with twitter
Idaho to collect $1.65M in drug pricing settlement - BusinessWeek Tweet this news
BusinessWeek--Attorney General Lawrence Wasden says in 2003, -Sandoz- reported its generic version of Prozac sold for an average wholesale price of nearly $2.60 a pill. ... - Date : Tue, 19 Oct 2010 04:22:12 GMT+00:00
Tainted injectables recalled by Sandoz, B. Braun - FiercePharma Tweet this news
FiercePharma--First, the Novartis generics unit -Sandoz- has initiated a recall of 24 lots of methotrexate, which is used to treat rheumatoid arthritis and psoriasis, ... - Date : Thu, 28 Oct 2010 15:23:32 GMT+00:00
Late October marks recall-o-rama - FiercePharma Manufacturing Tweet this news
FiercePharma Manufacturing---Sandoz- is recalling of two sizes of methotrexate injection vials because of they may contain glass flakes. The flakes resulted from delamination of glass ... - Date : Tue, 02 Nov 2010 12:46:06 GMT+00:00
Court lifts preliminary injunction for alleged imminent patent infringement - International Law Office Tweet this news
International Law Office--The ex parte preliminary injunction was granted by a court order dated May 4 2010, prohibiting -Sandoz- from launching and commercialising its generic version ... - Date : Tue, 02 Nov 2010 05:27:03 GMT+00:00
Health Highlights: Oct. 29, 2010 - BusinessWeek Tweet this news
BusinessWeek--Possible contamination with glass flakes has prompted the recall of two sizes of methotrexate injection vials sold under the -Sandoz- and Parenta brands, ... - Date : Fri, 29 Oct 2010 20:31:50 GMT+00:00
Sandoz Recalls Methotrexate Injections USP - MyHealthNewsDaily Tweet this news
MyHealthNewsDaily---Sandoz- Inc. has initiated a voluntary recall in the US of all 50mg/2mL and 250mg/10mL vials of -Sandoz- and Parenta brand Methotrexate Injection, ... - Date : Mon, 01 Nov 2010 06:08:34 GMT+00:00
Momenta profit beats estimates - Reuters Tweet this news
Reuters--O) reported better-than-expected quarterly results, helped by a strong launch of blood thinner enoxaparin by its partner -Sandoz-, sending its shares up 4 ... - Date : Mon, 01 Nov 2010 13:30:05 GMT+00:00
Sandoz: Mohit Malhotra is the new Country Head - Franchiseindia.com Tweet this news
Franchiseindia.com---Sandoz-, the generic subsidiary of drugmaker Novaritis, has appointed Mohit Malhotra as its new country head. He would also head the profile of commercial ... - Date : Sat, 31 Jul 2010 08:45:37 GMT+00:00
Mylan 2Q Profit Down 7.2% On Lower Sales, Margins - Wall Street Journal Tweet this news
Wall Street Journal--Mylan--the world's third-largest generic-drug maker by sales after Novartis AG's (NVS) generic arm, -Sandoz- ,and Teva Pharmaceutical Industries Ltd. ... - Date : Wed, 28 Jul 2010 21:18:11 GMT+00:00
FDA approves Lannett's generic for Sandoz weight-loss drug - Philadelphia Business Journal Tweet this news
Philadelphia Business Journal--Inc. for its generic version of Phentermine hydrochloride, a weight-reduction medicine marketed by -Sandoz-. Phentermine hydrochloride is used as a short-term ... - Date : Tue, 20 Jul 2010 17:48:35 GMT+00:00

Swiss Swiss Market Index companies of Switzerland

ABB * Actelion * Adecco * Credit Suisse * Holcim * Julius Bär * Lonza Group * Nestlé * Novartis * Richemont * Roche * SGS * Swatch Group * Swiss Re * Swisscom * Syngenta * Synthes * Transocean * UBS * Zurich Financial |



Privacy | Sitemap